Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-06-14
1984-01-24
Trousof, Natalie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
2602452R, 424263, 424271, A61K 31545, A61K 3143, C07D49900
Patent
active
044276788
ABSTRACT:
beta-Lactamase inhibitors which are 6-alpha- and 6-beta(aminomethyl)pencillanic acid 1,1-dioxides which are substituted on amino nitrogen with benzyl, hydroxybenzyl, picolyl or phenethyl; pharmaceutically-acceptable salts thereof; conventional esters thereof hydrolyzable in vivo; pharmaceutical compositions thereof with conventional beta-lactam antibiotics; and a method of treating bacterial infections with said pharmaceutical compositions.
REFERENCES:
patent: 4207323 (1980-06-01), Beattie et al.
patent: 4234579 (1979-03-01), Barth
patent: 4237051 (1980-02-01), McCombie
patent: 4287181 (1981-09-01), Kellogg
Sheehan et al., J. Org. Chem., 42, pp. 4045-4048 (1977).
Blackwood Robert K.
Clarke Vera C.
Frost Albert E.
Knuth Charles J.
Pfizer Inc.
LandOfFree
6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-l does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-l, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-l will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1287150